Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S, a leading global healthcare company, has announced the execution of a share repurchase program of up to DKK 20 billion over a 12-month period starting from February 6, 2024. As part of this program, the company has already repurchased 1,429,500 B shares for DKK 1.23 billion, demonstrating its commitment to drive shareholder value. This move reflects the company’s ongoing efforts to manage capital distribution effectively.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
